Curing Cancer: Easy Politics, Difficult Science
As the 2020 campaign season kicks off, both President Donald Trump and former Vice President Joe Biden say they’ll cure cancer. If only it were that simple.
Search
Filter
Clear All1,041 - 1,060 of 1,592 Results
-
-
Trump’s Talk On Preexisting Conditions Doesn’t Match His Administration’s Actions
The administration’s position on a pending lawsuit to get the Affordable Care Act is one of the reasons experts said there’s cause for skepticism.
-
GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.
-
Trump Has Blessed States’ Exploration Of Importing Drugs. Will It Catch On?
Colorado, Florida and Vermont — with the support of President Donald Trump — are exploring plans to bring drugs across the border from Canada to help lower costs.
-
Podcast: KHN’s ‘What The Health?’ Is ‘Medicare For All’ Losing Steam?
Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the latest Democratic efforts to push “Medicare for All” in the U.S. House. They also review new initiatives to raise the federal minimum age to purchase tobacco to 21 and new lawsuits challenging the Trump administration’s actions on reproductive health. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
First Kidney Failure, Then A $540,842 Bill For Dialysis
He needed the lifesaving treatment — he never expected a half-million-dollar bill for 14 weeks of care.
By Jenny Gold -
Trump Administration Seeks More Health Care Cost Details For Consumers
President Donald Trump ordered the federal government to help consumers benefit from gaining fuller estimates about their health care costs. But whether it will be a game changer depends on the details.
-
Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes
Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.
-
Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
-
‘Medicare For All’ Emerges As Early Divide In First Democratic Debate
On the first of the Democrat’s two-night debate, only New York City Mayor Bill de Blasio and Massachusetts Sen. Elizabeth Warren offered full support for a single-payer system that would banish private health insurance.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Listen: What’s Up With Trump’s Sudden Turnaround On Health Care?
President Donald Trump promises that Republicans will be the “party of health care” and seeks to have a court overturn the Affordable Care Act. But that leaves some Republican lawmakers nervous about bringing the contentious issue up before the 2020 elections. KHN’s Julie Rovner talks to “Detroit Today” host Stephen Henderson about the implications of the president’s moves.
-
Texas Is Latest State To Attack Surprise Medical Bills
A new state law says hospitals and insurers will have to work it out among themselves when they can’t agree on a price -- instead of sending huge bills to patients. “Bill of the Month” patient Drew Calver galvanized attention on the issue after he told his story to KHN, NPR and "CBS This Morning."
-
Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads — just like side effects.
By Julie Appleby and Sydney Lupkin -
FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?
The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.
-
Podcast: KHN’s ‘What The Health?’ ‘Conscience’ Rules, Rx Prices and Still More Medicare
Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest news about the Trump administration’s effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.
-
Lawmakers Push To Stop Surprise ER Billing
Millions of Californians are vulnerable to hefty surprise medical bills from their trips to the emergency room. Now, state lawmakers are considering a measure to cap how much out-of-network hospitals can charge privately insured patients for emergency care, which could serve as a model for other states.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.